Skip to NavigationSkip to content

News

0
Gilead's Biktarvy has been awarded marketing authorisation in the European Union from the European Commission for the treatment of HIV-1 infection.
0
Sophiris has revealed that a patient death had prompted it to put the brakes on its Phase 2b investigation into the efficacy of its pore-forming...
0
Eli Lilly has announced new data on Trulicity and investigational 3.0 and 4.5mg doses of dulaglutide, revealing that all three provided “...
0
Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson has announced she is to retire from her role and the company effective 1 October...

Features

Pharmafocus caught up with Vertex Pharma's Simon Lem to discuss his journey throughout the industry and the importance of the steps he's taken...